Expression of CRABP1, GRP, and RERG mRNA in clinically non-functioning and functioning pituitary adenomas

Journal of Endocrinological Investigation

Volumn 34, Issue 8 SUPPL., 2011, Pages

  Chile, T ^a   Correa Giannella M L ^a   Fortes, M A H Z ^a   Bronstein, M D ^a   Cunha Neto, M B ^a   Giannella Neto, D ^a   Giorgi, R R ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

CRABP1; Gene expression; GRP; Pituitary adenomas; RERG

Indexed keywords

COMPLEMENTARY DNA; ESTROGEN; GASTRIN RELEASING PEPTIDE; HYPOPHYSIS HORMONE; MESSENGER RNA; RETINOIC ACID; RETINOIC ACID BINDING PROTEIN;

ACTH SECRETING CELL; ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELLULAR RETINOIC ACID BINDING PROTEIN 1 GENE; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GENE EXPRESSION; GENETIC LINKAGE; GENETIC SELECTION; GENOME; HORMONAL REGULATION; HORMONE RELEASE; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; MAJOR CLINICAL STUDY; MALE; NONFUNCTIONING PITUITARY ADENOMA; NUCLEOTIDE SEQUENCE; ONCOGENE; PROLACTIN SECRETING CELL; RAS LIKE ESTROGEN REGULATED GROWTH INHIBITOR GENE; REAL TIME POLYMERASE CHAIN REACTION; SPINAL CORD METASTASIS; VALIDATION STUDY;

ACTH-SECRETING PITUITARY ADENOMA; ADENOMA; ADOLESCENT; ADULT; AGED; GASTRIN-RELEASING PEPTIDE; GENE EXPRESSION; GTP PHOSPHOHYDROLASES; HUMANS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PITUITARY GLAND; PITUITARY NEOPLASMS; PROLACTIN; RECEPTORS, RETINOIC ACID; RNA, MESSENGER; YOUNG ADULT;

EID: 84855484337     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.3275/7481     Document Type: Article

References (45)

1. Greenman Y, Melmed S. Diagnosis and management of nonfunctioning pituitary tumors. Annu Rev Med 1996, 47: 95-106. (Pubitemid 26138875)
2. Moreno CS, Evans CO, Zhan X, Okor M, Desiderio DM, Oyesiku NM. Novel molecular signaling and classification of human clinically nonfunctional pituitary adenomas identified by gene expression profiling and proteomic analyses. Cancer Res 2005, 65: 10214-22. (Pubitemid 41743713)
3. Evans CO, Young AN, Brown MR, et al. Novel patterns of gene expression in pituitary adenomas identified by complementary deoxyribonucleic acid microarrays and quantitative reverse transcription-polymerase chain reaction. J Clin Endocrinol Metab 2001, 86: 3097-107. (Pubitemid 32673472)
4. Morris DG, Musat M, Czirják S, et al. Differential gene expression in pituitary adenomas by oligonucleotide array analysis. Eur J Endocrinol 2005, 153: 143-51. (Pubitemid 41030525)
5. Hussaini IM, Trotter C, Zhao Y, et al. Matrix metalloproteinase-9 is differentially expressed in nonfunctioning invasive and 15 noninvasive pituitary adenomas and increases invasion in human pituitary adenoma cell line. Am J Pathol 2007, 170: 356-65. (Pubitemid 47339213)
6. Hu J, Song H, Wang X, et al. Gene expression profiling in human null cell pituitary adenoma tissue. Pituitary 2007, 10: 47-52. (Pubitemid 46562807)
7. Giorgi RR, Correa-Giannella ML, Casarini AP, et al. Metallothionein isoform 3 gene is differentially expressed in corticotropin-producing pituitary adenomas. Neuroendocrinology 2005, 82: 208-14.
8. Paez-Pereda M, Kovalovsky D, Hopfner U, et al. Retinoic acid prevents experimental Cushing syndrome. J Clin Invest 2001, 108: 1123-31. (Pubitemid 32995370)
9. Castillo V, Giacomini D, Páez-Pereda M, et al. Retinoic acid as a novel medical therapy for Cushing's disease in dogs. Endocrinology 2006, 147: 4438-44. (Pubitemid 44268395)
10. Labeur M, Paez-Pereda M, Arzt E, Stada GK. Potential of retinoic acid derivatives for the treatment of corticotroph pituitary adenomas. Rev Endocr Metab Disord 2009, 10: 103-9.
11. Burdman JA, Pauni M, Heredia Sereno GM, Bordón AE. Estrogen receptors in human pituitary tumors. Horm Metab Res 2008, 40: 524-7.
12. Olsen L, Knigge U, Warberg J. Gastrin-releasing peptide stimulation of corticotropin secretion in male rats. Endocrinology 1992, 130: 2710-6.
13. Santos CV, Pazos-Moura CC, Moura EG. Effect of gastrin-releasing peptide (GRP) and GRP antagonists on TSH secretion from rat isolated pituitaries. Life Sci 1995, 57: 911-5.
14. Kentroti S, Dees WL, McCann SM. Evidence for a physiological role of hypothalamic gastrin-releasing peptide to suppress growth hormone and prolactin release in the rat. Proc Natl Acad Sci U S A 1988, 85: 953-7. (Pubitemid 18073944)
15. Rozen S, Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 2000, 132: 365-86.
16. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25: 402-8. (Pubitemid 34164012)
17. Lattuada D, Viganó P, Mangioni S, et al. Accumulation of retinoid X receptor-alpha in uterine leiomyomas is associated with a delayed ligand-dependent proteasome-mediated degradation and an alteration of its transcriptional activity. Mol Endocrinol 2007, 21: 602-12.
18. Huang Y, de la Chapelle A, Pellegata NS. Hypermethylation, but not LOH, is associated with the low expression of MT1G and CRABP1 in papillary thyroid carcinoma. Int J Cancer 2003, 104: 735-44. (Pubitemid 36418511)
19. Wu X, Blanck A, Norstedt G, Sahlin L, Flores-Morales A. Identification of genes with higher expression in human uterine leiomyomas than in the corresponding myometrium. Mol Hum Reprod 2002, 8: 246-54. (Pubitemid 34196351)
20. Hawthorn L, Stein L, Varma R, Wiseman S, Loree T, Tan D. TIMP1 and SERPIN-A overexpression and TFF3 and CRABP1 underexpression as biomarkers for papillary thyroid carcinoma. Head Neck 2004, 26: 1069-83. (Pubitemid 39601228)
21. Pfoertner S, Goelden U, Hansen W, et al. Cellular retinoic acid binding protein I: expression and functional influence in renal cell carcinoma. Tumour Biol 2005, 26: 313-23. (Pubitemid 41619462)
22. Kelley MJ, Linnoila RI, Avis IL, et al. Antitumor activity of a monoclonal antibody directed against gastrin-releasing peptide in patients with small cell lung cancer. Chest 1997, 112: 256-61. (Pubitemid 27343628)
23. Kiaris H, Schally AV, Nagy A, Sun B, Armatis P, Szepeshazi K. Targeted cytotoxic analogue of bombesin/gastrin-releasing peptide inhibits the growth of H-69 human small-cell lung carcinoma in nude mice. Br J Cancer 1999, 81: 966-71. (Pubitemid 29516139)
24. Kim S, Hu W, Kelly DR, Hellmich MR, Evers BM, Chung DH. Gastrin-releasing peptide is a growth factor for human neuroblastomas. Ann Surg 2002, 235: 621-30. (Pubitemid 34454149)
25. Qiao J, Kang J, Ishola TA, Rychahou PG, Evers BM, Chung DH. Gastrin-releasing peptide receptor silencing suppresses the tumorigenesis and metastatic potential of neuroblastoma. Proc Natl Acad Sci U S A 2008, 105: 12891-6.
26. Finlin BS, Gau CL, Murphy GA, et al. RERG is a novel ras-related, estrogen-regulated and growth-inhibitory gene in breast cancer. J Biol Chem 2001, 276: 42259-67.
27. Wang AG, Fang W, Han YH, et al. Expression of the RERG gene is gender-dependent in hepatocellular carcinoma and regulated by histone deacetyltransferases. J Korean Med Sci 2006, 21: 891-6. (Pubitemid 44611225)
28. Boylan JF, Gudas LJ. Overexpression of the cellular retinoic acid binding protein-I (CRABP-I) results in a reduction in differentiation-specific gene expression in F9 teratocarcinoma cells. J Cell Biol 1991, 112: 965-79. (Pubitemid 21909642)
29. Boylan JF, Gudas LJ. The level of CRABP-I expression influences the amounts and types of all-trans-retinoic acid metabolites in F9 teratocarcinoma stem cells. J Biol Chem 1992, 267: 21486-91.
30. Won JY, Nam EC, Yoo SJ, et al. The effect of cellular retinoic acid binding protein-I expression on the CYP26-mediated catabolism of all-trans retinoic acid and cell proliferation in head and neck squamous cell carcinoma. Metabolism 2004, 53: 1007-12. (Pubitemid 38988284)
31. Tanaka K, Imoto I, Inoue J, et al. Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma. Oncogene 2007, 26: 6456-68. (Pubitemid 47494215)
32. Wu Q, Lothe RA, Ahlquist T, et al. DNA methylation profiling of ovarian carcinomas and their in vitro models identifies HOXA9, HOXB5, SCGB3A1, and CRABP1 as novel targets. Mol Cancer 2007, 6: 45.
33. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, Issa JP. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A 1999, 96: 8681-6. (Pubitemid 29354851)
34. Lind GE, Kleivi K, Meling GI, et al. ADAMTSI, CRABP1, and NR3C1 identified as epigenetically deregulated genes in colorectal tumorigenesis. Cell Oncol 2006, 28: 259-72. (Pubitemid 44950097)
35. Ogino S, Cantor M, Kawasaki T, et al. CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies. Gut 2006, 55: 1000-6. (Pubitemid 43962613)
36. Wong JJ, Hawkins NJ, Ward RL Colorectal cancer: a model for epigenetic tumorigenesis. Gut 2007, 56: 140-8. (Pubitemid 46044900)
37. Fujiwara K, Davaadash B, Yatabe M, et al. Reduction of retinaldehyde dehydrogenase 1 expression and production in estrogen-induced prolactinoma of rat. Med Mol Morphol 2008, 41: 126-31.
38. Bondioni S, Angioni AR, Corbetta S, et al. Effect of 9-cis retinoic acid on dopamine D2 receptor expression in pituitary adenoma cells. Exp Biol Med 2008, 233: 439-46. (Pubitemid 351469300)
39. Donovan M, Olofsson B, Gustafson AL, Dencker L, Eriksson U. The cellular retinoic acid binding proteins. J Steroid Biochem Mol Biol 1995, 53: 459-65.
40. Jensen RT, Battey JF, Spindel ER, Benya RV. International Union of Pharmacology. LXVIII. Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states. Pharmacol Rev 2008, 60: 1-42. (Pubitemid 351439216)
41. Houben H, Vandenbroucke AT, Vemeyden AM, Denef C. Expression of the genes encoding bombesin-related peptides and their receptors in anterior pituitary tissue. Mol Cell Endocrinol 1993, 97: 159-64. (Pubitemid 23328183)
42. Houben H, Denef C. Evidence for the presence of gastrin-releasing peptide immunoreactivity in rat anterior pituitary corticotrophs and lactotrophs, AtT20 cells, and GH3 cells: failure to demonstrate participation in local control of hormone release. Endocrinology 1991, 128: 3208-18.
43. Schulz S, Röcken C, Schulz S. Immunohistochemical detection of bombesin receptor subtypes GRP-R and BRS-3 in human tumors using novel antipeptide antibodies. Virchows Arch 2006, 449: 421-7. (Pubitemid 44451316)
44. Chaidarun SS, Swearingen B, Alexander JM. Differential expression of estrogen receptor-beta (ER beta) in human pituitary tumors: functional interactions with ER alpha and a tumor-specific splice variant. J Clin Endocrinol Metab 1998, 83: 3308-15. (Pubitemid 28500977)
45. Chaidarun SS, Klibanski A. Gonadotropinomas. Semin Reprod Med 2002, 20: 339-48. (Pubitemid 36043724)